TABLE 1.
Number (%) | SD | |
Cases | 65 | |
Average follow-up | 101 wk | |
Average age | 62 yrs | 18.6 yrs |
Men | 42 (65) | |
Women | 23 (35) | |
Eye | ||
Right | 32 (49) | |
Left | 33 (51) | |
Injury type | ||
Blunt | 61 (94) | |
Penetrating | 4 (6) | |
Graft age at the time of injury | 13.6 yrs | 11.52 yrs |
Wound length | 6.4 h | 2.4 h |
Suprachoroidal hemorrhage | 19 (29) | |
Zone of rupture | ||
I | 63 (97) | |
II | 2 (3) | |
Quadrants of dehiscence | ||
Superonasal | 35 (52) | |
Superotemporal | 31 (46) | |
Inferotemporal | 51 (75) | |
Inferonasal | 55 (81) | |
Initial BCVA* | ||
NLP | 7 (11) | |
LP | 24 (37) | |
HM-CF | 30 (46) | |
20/400 or better | 3 (5) | |
Mean | 2.45 LogMAR | 0.41 |
Final BCVA | ||
NLP | 20 (31) | |
LP | 12 (18) | |
HM | 13 (20) | |
CF | 6 (9) | |
20/200–20/50 | 6 (9) | |
20/40 or better | 8 (12) | |
Mean | 2.17 LogMAR | 0.99 |
OTS* | ||
Category 1 | 6 (9) | |
Category 2 | 27 (42) | |
Category 3 | 30 (46) | |
Category 4 | 1 (2) | |
Follow-up duration | 339 wk | 84 wk |
BCVA, best-corrected visual acuity; category 1 = 0 to 44 points, category 2 = 45 to 65 points, category 3 = 66 to 80 points, category 4 = 81 to 91 points, category 5 = 92 to 100 points.
1 pt unable to measure.